Administration of gamma‐aminobutyric acid effectively suppressed M1 macrophage activation in both the gastrocnemius muscle and spleen, reduced proinflammatory cytokines TNFα and IL‐6, and consequently alleviated sarcopenia [347]. The gene discussed is TNF; the disease is sarcopenia.